Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AQUABOUNTY TECHNOLOGIES INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0
0.05
0.08
0.19
0.13
1.17
3.14
2.47
Cost of revenue
0
1.19
2.63
3.57
13.6
15.3
Gross profit
0
-1.14
-2.54
-3.39
-10.5
-12.8
Research and development
3.43
3.37
3.46
2.36
2.36
2.15
0.9
0.51
0.2
Selling and marketing
0.86
0.8
0.3
0.71
0.53
1.26
1.14
0.65
0.19
0.01
General and administrative
3.78
3.92
4.07
6.72
6.8
9.1
9.79
12.5
9.04
4.01
Operating expenses
8.07
9.29
10.5
13.4
16.4
23.3
25.5
Operating income
-8.07
-9.23
-10.4
-13.2
-16.2
-22.1
-22.3
-13.7
-9.63
-4.02
Interest expense
0.4
0.02
0.02
0.06
0.15
0.32
0.29
0.3
1.74
0.21
Other non-operating income
-0.41
-0.03
-0.02
-0.05
-0.15
-0.2
0.17
-0.17
-1.75
1.79
Pre-tax income
-8.47
-9.26
-10.4
-13.2
-16.4
-22.3
-22.2
-13.8
-11.4
-2.23
Income tax
0
0
0
0
0
0
0
0
0
Income from continuing operations
370
388
Net income
-8.47
-9.26
-10.4
-13.2
-16.4
-22.3
-22.2
-27.6
-149
-18.5
EBITDA
-7.91
-9.05
-9.52
-11.9
-14.8
-20.3
-20.3
-11.5
-8.72
EPS, basic
-29.83
-19.76
-17.53
-12.31
-8.39
-5.97
-5.78
-7.17
-38.65
-4.77
EPS, diluted
-29.83
-19.76
-17.53
-12.31
-8.39
-5.97
-5.78
-7.17
-38.65
-4.77
Shares, basic (weighted)
0.28
0.47
0.7
1.08
1.95
3.72
3.83
3.84
3.86
3.87
Shares, diluted (weighted)
0.28
0.47
0.7
1.08
1.95
3.72
3.83
3.84
3.86
3.87
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
3.34
0.51
3
2.8
95.8
88.5
102
8.2
0.23
0.5
Short-term investments
102
Receivables
0.34
0.86
Inventory
0
0.17
0.08
1.23
1.53
1.26
2.28
1.73
Other current assets
0.07
0.39
0.15
0.04
0.41
1.54
2.13
1.15
0.29
0.27
Total current assets
3.57
1.39
3.51
4.48
97.7
193
106
31
11.3
10.3
Property, plant and equipment
1.72
21.8
23.7
25.1
26.9
33.8
106
144
22.7
Lease right-of-use assets
0
0.4
0.34
0.28
0.22
0.08
0.05
0.02
Intangible assets
0.2
0.18
0.17
0.16
0.25
0.23
0.22
0.2
Other non-current assets
0.02
0.16
0.08
0.03
0.08
0.08
0.06
0.05
Total assets
5.71
23.7
27.7
30.2
126
228
214
188
34.1
10.3
Accounts payable
0.16
1.09
0.37
0.81
0.8
4.32
12
12.1
0.89
0.34
Accrued liabilities
0.24
0.36
0.22
0.24
0.58
0.87
1.02
0.34
0.98
0.91
Short-term debt
0.02
0.05
0.07
0.16
0.26
0.63
2.39
0.52
1.26
Total current liabilities
1.04
2.72
0.92
1.69
2.08
5.89
15.4
14.8
16.2
8.75
Long-term debt
2.65
3.03
3.52
4.43
8.53
8.52
6.29
4.5
2
3.49
Lease liabilities
0
0.35
0.29
0.22
0.2
0.05
0.02
Total liabilities
3.68
5.75
4.44
6.47
10.9
14.6
21.9
22.5
18.2
12.2
Total debt
2.66
3.08
3.59
4.6
8.87
9.22
8.73
5.06
3.26
4.12
Paid-in capital
102
127
143
156
264
385
385
386
386
386
Retained earnings
-99.3
-109
-119
-132
-149
-171
-193
-221
-370
-388
Other comprehensive income
-0.29
-0.21
-0.57
-0.36
-0.27
-0.26
-0.52
-0.41
-0.69
Shareholders' equity
2.03
18
23.2
23.8
115
214
192
165
15.8
-1.89
Total equity
2.03
18
23.2
23.8
115
214
192
165
15.8
-1.89
Total liabilities and equity
5.71
23.7
27.7
30.2
126
228
214
188
34.1
10.3
Shares outstanding
0.35
0.48
0.81
1.16
2.98
3.81
3.83
3.85
3.87
3.88
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-8.47
-9.26
-10.4
-13.2
-16.4
-22.3
-22.2
-27.6
-149
-18.5
Depreciation and amortization
0.15
0.18
0.84
1.29
1.49
1.79
2.02
2.16
0.9
Stock-based compensation
0.22
0.12
0.26
0.87
0.44
0.39
0.54
0.54
0.3
0.07
Change in inventory
0
-0.17
0.09
-1.15
-0.28
0.27
-1.03
0.55
1.72
Change in payables
0.34
0.63
-0.97
0.61
0.15
0.23
-0
-0.05
0.61
-2.17
Cash from operations
-7.45
-9.1
-9.82
-11.2
-14.3
-20.5
-21
-24.2
-13.9
-8.74
Capital expenditures
-0.93
-18.9
-4.01
-2.32
-3.98
-5.71
-67.5
-68.9
-2.93
Purchases of investments
-188
-47.6
Cash from investing
-1.07
-19
-4.08
-2.46
-3.24
-108
34.4
-68.9
7.56
7.13
Debt issued
0.55
0.26
0.77
0.9
4.22
0.61
0.48
0.42
6.93
3.28
Stock issued
0
25
10.6
12.4
105
119
Cash from financing
10.5
25.2
16.4
13.5
111
121
-0.16
-0.31
-2.66
1.87
Exchange rate effect
-0.01
0.08
-0.05
0.02
-0.02
0.04
0
0
-0.01
0.01
Net change in cash
2.01
-2.83
2.5
-0.2
93.5
-6.8
13.2
-93.4
-8.97
0.27
Free cash flow
-8.38
-28
-13.8
-13.6
-18.3
-26.2
-88.5
-93.1
-16.8
Interest paid
0.01
0.02
0.02
0.06
0.11
0.3
0.27
0.22
1.7
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.95 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-652.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-156.7%
Net income / average total assets.
Return on invested capital (ROIC)
-263.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-111.9%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-69.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-63.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-39.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
14.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.26x
Current assets / current liabilities.
Quick ratio
0.72x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.69x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$1.39
Cash from operations / diluted weighted shares.
Book value per share
$0.55
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
1.74x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.74x
Market cap / tangible book value, when positive.
Earnings yield
-376.1%
Net income / market cap (the inverse of P/E).
Was AQUABOUNTY TECHNOLOGIES INC profitable in fiscal 2025?
No. It reported a net loss of $18.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.